1.46
0.00 (0.00%)
| Penutupan Terdahulu | 1.46 |
| Buka | 1.46 |
| Jumlah Dagangan | 60,504 |
| Purata Dagangan (3B) | 94,353 |
| Modal Pasaran | 6,274,697 |
| Harga / Buku (P/B) | 0.940 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Aug 2026 |
| EPS Cair (TTM) | -0.700 |
| Nisbah Semasa (MRQ) | 1.93 |
| Aliran Tunai Operasi (OCF TTM) | -9.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.87 M |
| Pulangan Atas Aset (ROA TTM) | -106.68% |
| Pulangan Atas Ekuiti (ROE TTM) | -285.79% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Acurx Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 0.0 |
| Purata | 0.50 |
|
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company’s segment consists of the development of clinical and preclinical product candidates for the development of the Company’s proprietary new therapies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.95% |
| % Dimiliki oleh Institusi | 18.21% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Prospect Financial Services Llc | 31 Mar 2026 | 13,785 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |